Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1CNS 1

Conditions

Brain Neoplasms 1699Glioblastoma 1307Glioma 992Neuroblastoma 408Central Nervous System Neoplasms 384Astrocytoma 383Gliosarcoma 286Oligodendroglioma 237Neoplasms 226Breast Neoplasms 216Meningioma 179Medulloblastoma 172Carcinoma, Non-Small-Cell Lung 149Recurrence 147Neoplasm Metastasis 138Lung Neoplasms 138Ependymoma 127Melanoma 118Sarcoma 116Neurofibromatosis 1 110Meningeal Carcinomatosis 107Lymphoma 94Neuroma, Acoustic 82Diffuse Intrinsic Pontine Glioma 81Precursor Cell Lymphoblastic Leukemia-Lymphoma 79Head and Neck Neoplasms 79Ovarian Neoplasms 73Lymphoma, Follicular 73Pheochromocytoma 71Paraganglioma 68

Interventions

thymoglobulin 1prednylidene 1deltacortene 1carmustine, poliferprosan 20 drug combination 1Prednisone 1Peripheral Blood Stem Cell Transplantation 1Melphalan 1Etoposide 1Cytarabine 1Carmustine 1Antilymphocyte Serum 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Polyradiculoneuropathy, Chronic Inflammatory Demyelinating × CNS × Clear all
NCT00716066 2026-02-27

Autologous Stem Cell Transplant for Neurologic Autoimmune Diseases

Fred Hutchinson Cancer Center

Phase 2 Active not recruiting
53 enrolled
CNS

Rasmussen subacute encephalitis, Autoimmune Diseases, Myasthenia Gravis, Neuromyelitis Optica, Lambert-Eaton Myasthenic Syndrome, Stiff-Person Syndrome, Autoimmune Diseases of the Nervous System, Polyradiculoneuropathy, Chronic Inflammatory Demyelinating, Vasculitis, Central Nervous System, Opsoclonus-Myoclonus Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡